| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/J.JRN.2010.06.006 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S1051227610001457?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S1051227610001457?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 20797577 |
| P2093 | author name string | Gabriel Mircescu | |
| Simona Stancu | |||
| Liliana Bârsan | |||
| Dan Munteanu | |||
| Lavinia O. Brătescu | |||
| P2860 | cites work | Hepcidin, a urinary antimicrobial peptide synthesized in the liver | Q24290609 |
| IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin | Q24568204 | ||
| Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein | Q28214986 | ||
| Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease | Q28235112 | ||
| Hepcidin: from discovery to differential diagnosis | Q28263177 | ||
| The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney | Q28568337 | ||
| Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System | Q33240234 | ||
| Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients | Q33303027 | ||
| Iron Deficiency and Erythropoiesis: New Diagnostic Approaches | Q35538677 | ||
| Suppression of hepcidin during anemia requires erythropoietic activity | Q35848905 | ||
| Mechanisms of disease: The role of hepcidin in iron homeostasis--implications for hemochromatosis and other disorders | Q36304041 | ||
| Molecular control of iron transport | Q36710628 | ||
| Body iron metabolism and pathophysiology of iron overload | Q37205002 | ||
| Hepcidin--a potential novel biomarker for iron status in chronic kidney disease | Q37211057 | ||
| The role of hepcidin in iron homeostasis and anemia in hemodialysis patients. | Q37403822 | ||
| Hepcidin for clinicians | Q37531547 | ||
| Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations | Q40342738 | ||
| Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization | Q41907959 | ||
| Hepcidin regulation: ironing out the details | Q42734886 | ||
| Is hepcidin the star player in iron metabolism in chronic kidney disease? | Q48007110 | ||
| Immunoassay for human serum hepcidin | Q56489921 | ||
| Hepcidin: a molecular link between inflammation and anaemia | Q75434634 | ||
| Does hepcidin affect erythropoiesis in hemodialysis patients? | Q79374702 | ||
| Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis | Q80160545 | ||
| Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? | Q81318673 | ||
| Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate | Q84778579 | ||
| P433 | issue | 5 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | iron deficiency | Q1313081 |
| P304 | page(s) | S77-83 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Journal of Renal Nutrition | Q6295855 |
| P1476 | title | Is hepcidin-25 a clinically relevant parameter for the iron status in hemodialysis patients? | |
| Is Hepcidin-25 a Clinically Relevant Parameter for the Iron Status in Hemodialysis Patients? | |||
| P478 | volume | 20 |
| Q87820193 | Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency |
| Q39701396 | Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients |
| Q36664001 | Serum Hepcidin Levels in Childhood-Onset Ischemic Stroke: A Case-Control Study |
| Q36513798 | Serum hepcidin levels and iron parameters in children with iron deficiency |
| Q38051056 | Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations? |
| Q34596298 | The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. |
Search more.